Cargando…

An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy

OBJECTIVES: Non‐melanoma skin cancers are the most frequently occurring type of cancer worldwide. They can be effectively treated using topical dermatological photodynamic therapy (PDT) employing protoporphyrin IX (PpIX) as the active photosensitising agent as long as the disease remains superficial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anayo, Lizette, Magnussen, Anette, Perry, Alexis, Wood, Mark, Curnow, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032951/ https://www.ncbi.nlm.nih.gov/pubmed/29603761 http://dx.doi.org/10.1002/lsm.22809

Ejemplares similares

Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy
por: Magnussen, Anette, et al.
Publicado: (2021)

Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug
por: Curnow, Alison, et al.
Publicado: (2019)

Regression Analysis of Protoporphyrin IX Measurements Obtained during Dermatological Photodynamic Therapy
por: Tyrrell, Jessica, et al.
Publicado: (2019)

The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
por: Berg, K., et al.
Publicado: (1996)

Photodynamic action of protoporphyrin IX derivatives on Trichophyton rubrum
por: Ramos, Rogério Rodrigo, et al.
Publicado: (2016)

Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy
por: Johnson, Renjith P, et al.
Publicado: (2012)

Photodynamic Activity of Protoporphyrin IX-Immobilized Cellulose Monolith for Nerve Tissue Regeneration
por: Lee, Ji Hye, et al.
Publicado: (2022)

Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy
por: Desgranges, Stéphane, et al.
Publicado: (2022)

Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin
por: Ruiz, Alberto J., et al.
Publicado: (2019)

Brazilian Green Propolis Extract Synergizes with Protoporphyrin IX-mediated Photodynamic Therapy via Enhancement of Intracellular Accumulation of Protoporphyrin IX and Attenuation of NF-κB and COX-2
por: Wang, Cheng-Cheng, et al.
Publicado: (2017)

Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.
por: Svanberg, K., et al.
Publicado: (1996)

Design and synthesis of a 4-aminoquinoline-based molecular tweezer that recognizes protoporphyrin IX and iron(iii) protoporphyrin IX and its application as a supramolecular photosensitizer
por: Hisamatsu, Yosuke, et al.
Publicado: (2018)

Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope
por: Neris, Romulo L. S., et al.
Publicado: (2018)

Reddish Colour in Cooked Ham Is Developed by a Mixture of Protoporphyrins Including Zn-Protoporphyrin and Protoporphyrin IX
por: Giménez-Campillo, Claudia, et al.
Publicado: (2022)

Protoporphyrin IX Binds to Iron(II)-Loaded and to Zinc-Loaded Human Frataxin
por: Bernardo-Seisdedos, Ganeko, et al.
Publicado: (2023)

Simultaneous determination of protoporphyrin IX and magnesium protoporphyrin IX in Arabidopsis thaliana and Camellia sinensis using UPLC-MS/MS
por: Zhang, Chenyu, et al.
Publicado: (2023)

The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.
por: Leveckis, J., et al.
Publicado: (1995)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

In Vitro Comparison of Hypericin and 5-Aminolevulinic Acid-Derived Protoporphyrin IX for Photodynamic Inactivation of Medulloblastoma Cells
por: Ritz, Rainer, et al.
Publicado: (2012)

Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma
por: Wang, Mian, et al.
Publicado: (2017)

Catechin reduces phototoxic effects induced by protoporphyrin IX-based photodynamic therapy in the chick embryo chorioallantoic membrane
por: Joniová, Jaroslava, et al.
Publicado: (2020)

Increased fluorescence observation intensity during the photodynamic diagnosis of deeply located tumors by fluorescence photoswitching of protoporphyrin IX
por: Ogbonna, Sochi J., et al.
Publicado: (2023)

Spectroscopic and Theoretical Investigation of β-Lactoglobulin Interactions with Hematoporphyrin and Protoporphyrin IX
por: Wang, Yun, et al.
Publicado: (2021)

δ-Aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro
por: Gibson, S L, et al.
Publicado: (1999)

Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response
por: Yang, Xue, et al.
Publicado: (2016)

Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy
por: Nakayama, Taku, et al.
Publicado: (2016)

Binding of Immunoglobulin G to Protoporphyrin IX and Its Derivatives: Evidence the Fab Domain Recognizes the Protoporphyrin Ring
por: Orino, Koichi
Publicado: (2019)

Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.
por: Wyld, L., et al.
Publicado: (1997)

Characterization and standardization of tissue-simulating protoporphyrin IX optical phantoms
por: Marois, Mikael, et al.
Publicado: (2016)

Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX
por: Al-Ani, Ali W., et al.
Publicado: (2019)

How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
por: Wulf, Hans Christian, et al.
Publicado: (2021)

The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species
por: Dogra, Yuktee, et al.
Publicado: (2016)

Studies on the binding of nitrogenous bases to protoporphyrin IX iron(II) in aqueous solution at high pH values
por: Silver, Jack, et al.
Publicado: (2022)

GENETIC CONTROL OF CHLOROPHYLL BIOSYNTHESIS IN CHLAMYDOMONAS : Analysis of Mutants at Two Loci Mediating the Conversion of Protoporphyrin-IX to Magnesium Protoporphyrin
por: Wang, Wei-Yeh, et al.
Publicado: (1974)

Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia
por: Otsuka, Shimpei, et al.
Publicado: (2015)

eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy
por: Fan, Zhichao, et al.
Publicado: (2016)

A study of concentration changes of Protoporphyrin IX and Coproporphyrin III in mixed samples mimicking conditions inside cancer cells for Photodynamic Therapy
por: Landes, Rainer, et al.
Publicado: (2018)

Chlorophyll-deficient mutants of Chlamydomonas reinhardtii that accumulate magnesium protoporphyrin IX
por: Meinecke, Linda, et al.
Publicado: (2010)

Quantification of Protoporphyrin IX Accumulation in Glioblastoma Cells: A New Technique
por: Lawrence, Johnathan E., et al.
Publicado: (2014)

Mg-Protoporphyrin IX Signals Enhance Plant’s Tolerance to Cold Stress
por: Zhang, Zhong-Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3p2v6neld6l46pbnusqj9oj1pg